-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Stock symbol
-
EFX
-
Transactions as of
-
May 24, 2024
-
Transactions value $
-
-$244,361
-
Form type
-
4
-
Date filed
-
5/29/2024, 04:39 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EFX |
Common Stock |
Options Exercise |
$991K |
+5.18K |
+30.67% |
$191.44 |
22.1K |
May 24, 2024 |
Direct |
F1, F2 |
transaction |
EFX |
Common Stock |
Sale |
-$56.7K |
-241 |
-1.09% |
$235.46 |
21.8K |
May 24, 2024 |
Direct |
F1, F2, F3 |
transaction |
EFX |
Common Stock |
Sale |
-$77.1K |
-324 |
-1.48% |
$238.11 |
21.5K |
May 24, 2024 |
Direct |
F1, F2, F4 |
transaction |
EFX |
Common Stock |
Sale |
-$114K |
-476 |
-2.21% |
$240.07 |
21K |
May 24, 2024 |
Direct |
F1, F2, F5 |
transaction |
EFX |
Common Stock |
Sale |
-$221K |
-931 |
-4.43% |
$236.92 |
20.1K |
May 24, 2024 |
Direct |
F1, F2, F6 |
transaction |
EFX |
Common Stock |
Sale |
-$767K |
-3.21K |
-15.96% |
$239.21 |
16.9K |
May 24, 2024 |
Direct |
F1, F2, F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-5.18K |
-100% |
$0.00* |
0 |
May 24, 2024 |
Common Stock |
5.18K |
$191.44 |
Direct |
F1, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: